No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
Hamidreza Jamaati, Seyed Mohammadreza Hashemian, Behrooz Farzanegan, Majid Malekmohammad, Payam Tabarsi, Majid Marjani, Afshin Moniri, Zahra Abtahian, Sara Haseli, Esmaeil Mortaz, Alireza Dastan, Abdolreza Mohamadnia, Abdolbaset Vahedi, Fatemeh Monjazebi, Fatemeh Yassari, Lida Fadaeizadeh, Ali Saffaei, Farzaneh Dastan
European Journal of Pharmacology, doi:10.1016/j.ejphar.2021.173947
The aim of this study was to evaluate the clinical effects of dexamethasone administration in patients with mild to moderate acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 . The study included 50 patients who were randomly assigned to the dexamethasone group or control group. Dexamethasone was administered at a dose of 20 mg/day from day 1-5 and then at 10 mg/day from day 6-10. The need for invasive mechanical ventilation, death rate, duration of clinical improvement, length of hospital stay, and radiological changes in the computed tomography scan were assessed. The results revealed that 92% and 96% of patients in the dexamethasone and control groups, respectively, required noninvasive ventilation (P = 0.500). Among them, 52% and 44% of patients in the dexamethasone and control groups, respectively, required invasive mechanical ventilation (P = 0.389). At the end of the study, 64% of patients in the dexamethasone group and 60% of patients in the control group died (P = 0.500); the remaining patients were discharged from the hospital during the 28-day follow-up period. The median length of hospital stay was 11 days in the dexamethasone group and 6 days in the control group (P = 0.036) and the median length of hospital stay was 7 days in the dexamethasone group and 3 days in the control group (P < 0.001). No significant differences were observed in the other outcomes. This study showed that corticosteroid administration had no clinical benefit in patients with COVID-19-induced mild to moderate ARDS.
Declaration of competing interest None.
References
Chan, Yao, Yeung, Deng, Bao et al., Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset, J. Infect. Dis
Chatterjee, Nagi, Agarwal, Das, Banerjee et al., The 2019 novel coronavirus disease (COVID-19) pandemic: a review of the current evidence, Indian J. Med. Res
Chen, Hu, Zhang, Jiang, Han et al., Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial, medRxiv,
doi:10.1101/2020.03.22.20040758
Dastan, Saffaei, Mortazavi, Jamaati, Adnani et al., Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19, J. Global .Antimicrob. Resist
Dediego, Nieto-Torres, Regla-Nava, Jimenez-Guardeño, Fernandez-Delgado et al., Inhibition of NF-κB-Mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival, J. Virol
Dong, Hu, Gao, Discovering drugs to treat coronavirus disease 2019 (COVID-19), Drug Discoveries & Therapeutics
Grein, Ohmagari, Shin, Diaz, Asperges et al., Compassionate use of remdesivir for patients with severe covid-19, N. Engl. J. Med
Jamaati, Dastan, Tabarsi, Marjani, Saffaei et al., A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol, Iran. J. Pharm. Sci
Kil, Lee, Lee, Rhim, Youn et al., Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus, Crit. Care
Lansbury, Rodrigo, Leonardi-Bee, Nguyen-Van-Tam, Lim, Corticosteroids as adjunctive therapy in the treatment of influenza, Cochrane Database Syst. Rev
Masjedi, Esmaeil, Saffaei, Abtahi-Naeini, Pourazizi et al., Cytokine indexes in pemphigus vulgaris: perception of its immunpathogenesis and hopes for non-steroidal treatment, Iran. J. Pharm. Res. (IJPR) : IJPR
Mehta, Mcauley, Brown, Sanchez, Tattersall et al., COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet
Ni, Ding, Li, Zhao, Liu et al., Retrospective study of low-tomoderate dose glucocorticoids on viral clearance in patients with novel coronavirus pneumonia, Chin J Clin Infect Dis
Rhen, Cidlowski, Antiinflammatory action of glucocorticoids -New mechanisms for old drugs, N. Engl. J. Med
Rosa, Santos, Clinical trials on drug repositioning for COVID-19 treatment, Rev. Panam. Salud Públic
Sibila, Agustí, Torres, Corticosteroids in severe pneumonia, Eur. Respir. J
Singh, Majumdar, Singh, Misra, Role of corticosteroid in the management of COVID-19: a systemic review and a Clinician's perspective, Diabetes, Metab. Syndrome
Tang, Liu, Zhang, Xu, Ji et al., Cytokine storm in COVID-19: the current evidence and treatment strategies, Front. Immunol
Trilla, One world, one health: the novel coronavirus COVID-19 epidemic, Med. Clin
Villar, Ferrando, Martínez, Ambrós, Muñoz et al., Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial, The Lancet Respiratory Medicine
Wang, Jiang, He, Wang, Wang et al., Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China,
doi:10.1101/2020.03.06.20032342
Zha, Li, Pan, Tefsen, Li et al., Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19), Med. J. Aust
DOI record:
{
"DOI": "10.1016/j.ejphar.2021.173947",
"ISSN": [
"0014-2999"
],
"URL": "http://dx.doi.org/10.1016/j.ejphar.2021.173947",
"alternative-id": [
"S001429992100100X"
],
"article-number": "173947",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "European Journal of Pharmacology"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.ejphar.2021.173947"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2021 Elsevier B.V. All rights reserved."
}
],
"author": [
{
"affiliation": [],
"family": "Jamaati",
"given": "Hamidreza",
"sequence": "first"
},
{
"affiliation": [],
"family": "Hashemian",
"given": "Seyed MohammadReza",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Farzanegan",
"given": "Behrooz",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Malekmohammad",
"given": "Majid",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tabarsi",
"given": "Payam",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Marjani",
"given": "Majid",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Moniri",
"given": "Afshin",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Abtahian",
"given": "Zahra",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Haseli",
"given": "Sara",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Mortaz",
"given": "Esmaeil",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Dastan",
"given": "Alireza",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Mohamadnia",
"given": "Abdolreza",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Vahedi",
"given": "Abdolbaset",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Monjazebi",
"given": "Fatemeh",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Yassari",
"given": "Fatemeh",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Fadaeizadeh",
"given": "Lida",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Saffaei",
"given": "Ali",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Dastan",
"given": "Farzaneh",
"sequence": "additional"
}
],
"container-title": "European Journal of Pharmacology",
"container-title-short": "European Journal of Pharmacology",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2021,
2,
17
]
],
"date-time": "2021-02-17T06:26:42Z",
"timestamp": 1613543202000
},
"deposited": {
"date-parts": [
[
2022,
12,
24
]
],
"date-time": "2022-12-24T00:55:31Z",
"timestamp": 1671843331000
},
"indexed": {
"date-parts": [
[
2025,
6,
5
]
],
"date-time": "2025-06-05T20:28:45Z",
"timestamp": 1749155325803
},
"is-referenced-by-count": 74,
"issued": {
"date-parts": [
[
2021,
4
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
},
{
"URL": "https://doi.org/10.15223/policy-017",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
},
{
"URL": "https://doi.org/10.15223/policy-037",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
},
{
"URL": "https://doi.org/10.15223/policy-012",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
},
{
"URL": "https://doi.org/10.15223/policy-029",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
},
{
"URL": "https://doi.org/10.15223/policy-004",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
4,
1
]
],
"date-time": "2021-04-01T00:00:00Z",
"timestamp": 1617235200000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S001429992100100X?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S001429992100100X?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "173947",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2021,
4
]
]
},
"published-print": {
"date-parts": [
[
2021,
4
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1093/infdis/jiv392",
"article-title": "Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset",
"author": "Chan",
"doi-asserted-by": "crossref",
"first-page": "1904",
"journal-title": "J. Infect. Dis.",
"key": "10.1016/j.ejphar.2021.173947_bib1",
"volume": "212",
"year": "2015"
},
{
"article-title": "The 2019 novel coronavirus disease (COVID-19) pandemic: a review of the current evidence",
"author": "Chatterjee",
"issue": "2–3",
"journal-title": "Indian J. Med. Res.",
"key": "10.1016/j.ejphar.2021.173947_bib2",
"volume": "151",
"year": "2020"
},
{
"article-title": "Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial",
"author": "Chen",
"journal-title": "medRxiv",
"key": "10.1016/j.ejphar.2021.173947_bib3",
"year": "2020"
},
{
"article-title": "Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19",
"author": "Dastan",
"issue": "340–341",
"journal-title": "J. Global .Antimicrob. Resist.",
"key": "10.1016/j.ejphar.2021.173947_bib4",
"volume": "21",
"year": "2020"
},
{
"DOI": "10.1128/JVI.02576-13",
"article-title": "Inhibition of NF-κB-Mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival",
"author": "DeDiego",
"doi-asserted-by": "crossref",
"first-page": "913",
"journal-title": "J. Virol.",
"key": "10.1016/j.ejphar.2021.173947_bib5",
"volume": "88",
"year": "2014"
},
{
"DOI": "10.5582/ddt.2020.01012",
"article-title": "Discovering drugs to treat coronavirus disease 2019 (COVID-19)",
"author": "Dong",
"doi-asserted-by": "crossref",
"first-page": "58",
"journal-title": "Drug Discoveries & Therapeutics",
"key": "10.1016/j.ejphar.2021.173947_bib6",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2007016",
"article-title": "Compassionate use of remdesivir for patients with severe covid-19",
"author": "Grein",
"doi-asserted-by": "crossref",
"journal-title": "N. Engl. J. Med.",
"key": "10.1016/j.ejphar.2021.173947_bib7",
"volume": "382",
"year": "2020"
},
{
"article-title": "A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol",
"author": "Jamaati",
"first-page": "31",
"journal-title": "Iran. J. Pharm. Sci.",
"key": "10.1016/j.ejphar.2021.173947_bib8",
"volume": "19",
"year": "2020"
},
{
"DOI": "10.1186/cc10082",
"article-title": "Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus",
"author": "Kil",
"doi-asserted-by": "crossref",
"first-page": "413",
"journal-title": "Crit. Care",
"key": "10.1016/j.ejphar.2021.173947_bib9",
"volume": "15",
"year": "2011"
},
{
"article-title": "Corticosteroids as adjunctive therapy in the treatment of influenza",
"author": "Lansbury",
"journal-title": "Cochrane Database Syst. Rev.",
"key": "10.1016/j.ejphar.2021.173947_bib10",
"volume": "2",
"year": "2019"
},
{
"article-title": "Cytokine indexes in pemphigus vulgaris: perception of its immunpathogenesis and hopes for non-steroidal treatment",
"author": "Masjedi",
"first-page": "1223",
"journal-title": "Iran. J. Pharm. Res. (IJPR) : IJPR",
"key": "10.1016/j.ejphar.2021.173947_bib11",
"volume": "16",
"year": "2017"
},
{
"DOI": "10.1016/S0140-6736(20)30628-0",
"article-title": "COVID-19: consider cytokine storm syndromes and immunosuppression",
"author": "Mehta",
"doi-asserted-by": "crossref",
"first-page": "1033",
"journal-title": "Lancet",
"key": "10.1016/j.ejphar.2021.173947_bib12",
"volume": "395",
"year": "2020"
},
{
"article-title": "Retrospective study of low-to-moderate dose glucocorticoids on viral clearance in patients with novel coronavirus pneumonia",
"author": "Ni",
"journal-title": "Chin J Clin Infect Dis",
"key": "10.1016/j.ejphar.2021.173947_bib13",
"volume": "13",
"year": "2020"
},
{
"DOI": "10.1056/NEJMra050541",
"article-title": "Antiinflammatory action of glucocorticoids — New mechanisms for old drugs",
"author": "Rhen",
"doi-asserted-by": "crossref",
"first-page": "1711",
"journal-title": "N. Engl. J. Med.",
"key": "10.1016/j.ejphar.2021.173947_bib14",
"volume": "353",
"year": "2005"
},
{
"DOI": "10.26633/RPSP.2020.40",
"article-title": "Clinical trials on drug repositioning for COVID-19 treatment",
"author": "Rosa",
"doi-asserted-by": "crossref",
"first-page": "e40",
"journal-title": "Rev. Panam. Salud Públic",
"key": "10.1016/j.ejphar.2021.173947_bib15",
"volume": "44",
"year": "2020"
},
{
"DOI": "10.1183/09031936.00154107",
"article-title": "Corticosteroids in severe pneumonia",
"author": "Sibila",
"doi-asserted-by": "crossref",
"first-page": "259",
"journal-title": "Eur. Respir. J.",
"key": "10.1016/j.ejphar.2021.173947_bib16",
"volume": "32",
"year": "2008"
},
{
"DOI": "10.1016/j.dsx.2020.06.054",
"article-title": "Role of corticosteroid in the management of COVID-19: a systemic review and a Clinician's perspective",
"author": "Singh",
"doi-asserted-by": "crossref",
"first-page": "971",
"journal-title": "Diabetes, Metab. Syndrome",
"key": "10.1016/j.ejphar.2021.173947_bib17",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.3389/fimmu.2020.01708",
"article-title": "Cytokine storm in COVID-19: the current evidence and treatment strategies",
"author": "Tang",
"doi-asserted-by": "crossref",
"journal-title": "Front. Immunol.",
"key": "10.1016/j.ejphar.2021.173947_bib18",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1016/j.medcli.2020.02.002",
"article-title": "One world, one health: the novel coronavirus COVID-19 epidemic",
"author": "Trilla",
"doi-asserted-by": "crossref",
"first-page": "175",
"issue": "5",
"journal-title": "Med. Clin.",
"key": "10.1016/j.ejphar.2021.173947_bib19",
"volume": "154",
"year": "2020"
},
{
"DOI": "10.1016/S2213-2600(19)30417-5",
"article-title": "Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial",
"author": "Villar",
"doi-asserted-by": "crossref",
"first-page": "267",
"journal-title": "The Lancet Respiratory Medicine",
"key": "10.1016/j.ejphar.2021.173947_bib20",
"volume": "8",
"year": "2020"
},
{
"article-title": "Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China",
"author": "Wang",
"journal-title": "medRxiv",
"key": "10.1016/j.ejphar.2021.173947_bib21",
"year": "2020"
},
{
"DOI": "10.5694/mja2.50577",
"article-title": "Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)",
"author": "Zha",
"doi-asserted-by": "crossref",
"first-page": "416",
"journal-title": "Med. J. Aust.",
"key": "10.1016/j.ejphar.2021.173947_bib22",
"volume": "212",
"year": "2020"
}
],
"reference-count": 22,
"references-count": 22,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S001429992100100X"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"special_numbering": "C",
"subject": [],
"subtitle": [],
"title": "No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "897"
}